GLATIRAMER ACETATE
Active substance: Glatiramer
INJECTION, SOLUTION · GLATIRAMER ACETATE 20 mg/mL
United StatesActive
Marketing holder: Zydus Pharmaceuticals USA Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- GLATIRAMER ACETATE · 20 mg/mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-3923-76cc-b6e1-2169c2c9c6dc,01a1208c-9335-7dc5-b4f1-7972f9c0f342,01a1208c-ecaf-7910-b5a7-8b03191ea49a,01a1208c-ecb8-786b-97ca-7b54b3db8238,01a1208d-6fbb-7bea-ae8e-594aaf4273de;count=18 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 70710-1548
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- SUBCUTANEOUS
Sources
- product · openFDA NDC · 70710-1548 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 70710-1548 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 70710-1548 · Verified 2026-10-09 · open in source